UK biotech Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
23:23
Jan 31
Steve Diggle Founder, Vulpes Investment Management The David Lin Report
UK biotech cheap with global upside
UK biotech valuations are much lower than the US—at least half or more—yet the products are global. Steve relocated to Oxford and invests in Oxford University spinouts, giving him close local access to the Oxford, Cambridge, and London biotech clusters and cheap world-class IP.
UK biotech
HIGH

About UK biotech Investor Commentary

Across the available history and selected sources, Buzzberg tracks UK biotech across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Steve Diggle.